Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AQH | Ann: Suspension and Removal from Official List | 11/02/19 | 0 | 615 | |||
|
|||||||
AQH | Ann: Request for removal of APT Pipelines Ltd from official list | 11/01/19 | 0 | 517 | |||
|
|||||||
AQH | Ann: APA notes SEA Gas major contract commitments | 21/12/18 | 0 | 479 | |||
|
|||||||
AQH | Ann: APA signs East Coast Grid GTA variation | 19/12/18 | 0 | 419 | |||
|
|||||||
AQH | Ann: APA terminates RCR Tomlinson contract | 13/12/18 | 0 | 480 | |||
|
|||||||
AQH | Ann: Managing Director and CEO Mick McCormack to retire in 2019 | 13/12/18 | 0 | 429 | |||
|
|||||||
AQH | Ann: APA Supporting Summer Energy Needs | 10/12/18 | 0 | 440 | |||
|
|||||||
AQH | Ann: APA reconfirms FY2019 guidance outlook | 21/11/18 | 0 | 402 | |||
|
See All Discussions